As global markets navigate a muted response to new U.S. tariffs and mixed economic signals, the Asian tech sector remains a focal point for investors seeking high growth opportunities. With market ...

Stocks like Wipro, Axis Bank, LTIMindtree, Indian Hotels, Lupin, Tracxn Technologies, Capital Small Finance Bank, Veranda ...

Ligand Pharmaceuticals shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 80 to 84.

National Bank Financial analyst Maxim Sytchev, who has an “outperform” rating and $28 target, said he expects the sale of the ...

Going public is one of the biggest transitions a company can make. It’s a cultural, strategic, and financial shift for many ...

The new space is a free community service meant to help healthcare entrepreneurs connect with potential funders.

Over the last 7 days, the market has remained flat, while in the past 12 months it has risen by 14%, with earnings expected to grow by 15% per annum over the next few years. For investors willing to ...

The pharmaceutical sector continues to stand out as a resilient and highly profitable corner of the market, even amid global ...

Amidst the largely rangebound moves, the rupee's 1-month implied volatility has eased to a near one-month low of 4.2%, while the stock volatility gauge, India VIX, has retreated to 11.6 from around 14 ...

J.P. Morgan Research believes that the S&P 500 will close near 6,000 by year-end, aided by the double-digit growth in earnings.

Wealthfront Advisers LLC has significantly increased its investment in Amgen Inc., boosting its holdings by 30.7% in the ...